These director sales are routine and below the 0.1% market cap threshold for materiality. No actionable signal for traders; monitor for any C-suite insider activity or material corporate events.
Price Chart
Executive Summary
Two directors at PUMA BIOTECHNOLOGY sold a combined $242K in open-market shares on June 12, 2026, representing just 0.065% of the company's $373M market cap. The sales are trivial relative to company size and are accompanied by non-cash director stock grants, indicating routine portfolio rebalancing rather than a bearish signal.
Key Financial Metrics
Key Facts
- Director Jay M. Moyes sold 22,000 shares at $7.22 for $158,796 on June 12, 2026.
- Director Allison Dorval sold 11,610 shares at $7.20 for $83,579 on June 12, 2026.
- Three directors received non-cash stock grants of 27,000 shares each on June 11, 2026 ($0 value).
- Total insider sales of $242K represent only 0.065% of PBYI's $373M market cap.
- No C-suite executives participated in the sales.
Financial Impact
Insider sales of $242K are immaterial relative to $373M market cap (0.065%).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PBYI-1781568656124 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | SC 13D/A | $9.81 | awaiting T+20 | — | $10.92 (+11.31%) |
Sep 16, 2026 5w ago | Insider Cluster | $9.52 $10.52 | ▼ −10.50% | ▼ −9.30% | $10.92 (−14.71%) |
Jul 8, 2026 15w ago | Insider Cluster | $7.90 $8.12 | ▲ +2.78% | ▲ +0.54% | $10.92 (+38.23%) |
Jul 6, 2026 16w ago | 144 | $7.96 $7.69 | ▼ −3.39% | ▼ −4.72% | $10.92 (+37.19%) |
Jun 15, 2026 19w ago | Insider Cluster | $7.17 $8.28 | ▲ +15.48% | ▲ +15.28% | $10.92 (+52.30%) |
Jun 12, 2026 19w ago | 144 | $7.33 $8.00 | ▲ +9.14% | ▲ +7.36% | $10.92 (+48.98%) |
Feb 26, 2026 34w ago | 8-K | $5.70 $6.08 | ▲ +6.67% | ▲ +14.22% | $10.92 (+91.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers